Keywords: CEST & MT, Quantitative Imaging, APT
Amide Proton Transfer MRI shows clinical benefit in glioma imaging. Clinically useful APTw metrics should be sensitive to changes in amide concentration, a potential marker of tumour proliferation, and insensitive to T1 changes. To investigate sensitivity, simulations and in-vitro studies were performed over a range of amide concentrations and T1 values. In-vitro data included two varied concentration series, with and without T1-maintenance, and a constant concentration T1-vaired series. In-vitro results showed APT* had poor sensitivity, MTRrex was most sensitive to concentration and T1, AREX may overcorrect for T1, and MTRasym appears least sensitive to T1 while remaining sensitive to concentration.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords